Treatment of downbeat nystagmus with 3,4-diaminopyridine: a placebo-controlled study.
about
Interventions for disorders of eye movement in patients with strokePharmacotherapy of vestibular and ocular motor disorders, including nystagmusNeuropharmacology of vestibular system disordersCurrent treatment of vestibular, ocular motor disorders and nystagmusUpdate on the pharmacotherapy of cerebellar and central vestibular disordersThe physiological basis of therapies for cerebellar ataxiasCentral vestibular disordersCentral ocular motor disorders, including gaze palsy and nystagmus.Central oculomotor disturbances and nystagmus: a window into the brainstem and cerebellumThe treatment methods for post-stroke visual impairment: A systematic reviewNew methods for diagnosis and treatment of vestibular diseases.Eye disorders in patients with multiple sclerosis: natural history and management.Survey of management of acquired nystagmus in the United Kingdom.4-aminopyridine does not enhance flocculus function in tottering, a mouse model of vestibulocerebellar dysfunction and ataxia.The pharmacological treatment of nystagmus: a review.Symptomatic therapy in multiple sclerosis: a review for a multimodal approach in clinical practice.A randomized trial of 4-aminopyridine in EA2 and related familial episodic ataxiasConsensus paper: management of degenerative cerebellar disorders.Diplopia and eye movement disorders.Nystagmus: an update on treatment in adults.Real-time computer-based visual feedback improves visual acuity in downbeat nystagmus - a pilot study.What can acquired nystagmus tell us about congenital forms of nystagmus?Neuro-ophthalmology of type 1 Chiari malformation.Episodic ataxia type 2.An update on acquired nystagmus.The treatment and natural course of peripheral and central vertigo.Effects of acetyl-DL-leucine in patients with cerebellar ataxia: a case seriesMedical treatment of vestibular disorders.Diagnosis and treatment of vertigo and dizziness.Cerebellum and ocular motor control.What we know about the generation of nystagmus and other ocular oscillations: are we closer to identifying therapeutic targets?Pharmacotherapy of vestibular and cerebellar disorders and downbeat nystagmus: translational and back-translational research.Update on the Pharmacotherapy of Cerebellar Ataxia and Nystagmus.Aminopyridines for the treatment of neurologic disorders.Resting in darkness improves downbeat nystagmus: evidence from an observational study.3,4-diaminopyridine safety in clinical practice: an observational, retrospective cohort study.The effects of gabapentin and memantine in acquired and congenital nystagmus: a retrospective study.Treatment with 4-aminopyridine improves upper limb tremor of a patient with multiple sclerosis: a video case report.Dalfampridine in patients with downbeat nystagmus--an observational study.[Vertigo and dizziness: the neurologist's perspective].
P2860
Q24236162-6FF7DEE6-E722-4B92-A5D8-41AC2DEB0885Q24595123-8AEFBBAC-EF97-45F6-BCE1-004C7427BFC9Q24624927-E88C0D61-704F-48AE-BBF0-57A3A949E4D6Q24628964-9A213FE9-576D-4DD0-99AE-569218243996Q26753139-A5156E7F-5059-44E7-8B08-D8D209266844Q28075917-54D26F7D-61CA-4BDA-8954-AAC32E2D26DFQ28297171-A05AD065-50C4-4E75-B67E-A920A3838998Q30432497-D0E3DB0C-119B-40A2-A579-CB311B04E74CQ30475787-BD619501-41D0-465A-B01D-E60C2D5BCA95Q33695324-305F4496-5E19-4C90-8EF3-365CF60CFD25Q34344253-3C828EA1-0FB6-45C7-91E7-AD51B66D8ACBQ34399820-7F7B9CCD-ECD2-40C4-9F10-B3B6EEEAB2EFQ34531663-61EA584D-7BA2-4309-82FC-BB1DA8D237D7Q34603922-D7498502-255F-44BF-9F89-2C9CDC9B93C1Q34992227-DDEB65E9-184D-4231-A376-23C59A8AC7B5Q35018491-DACFC4B3-D197-4214-92E4-1CBF507D100FQ35104451-D8FDA019-D1DE-4F42-8BD0-F20C9D052E37Q35129909-84CA7B4B-E7CA-4329-B003-C4186AB7B90AQ35963576-EF842007-39BB-4B37-95FA-38E54B92B69DQ36150695-BDC1FC59-8243-4340-BA54-A9CC5FB9FB92Q36428360-667A6035-1FD4-4805-8DE2-4D132427E7CCQ36479515-A55754E0-07CD-4CAA-9AAC-CEB309DB6E34Q36522919-A6E7ED70-7622-49A3-9CEB-40A951952F33Q36774729-EDB82AE4-B44A-41C3-BF26-D560552C0135Q37102314-C1500506-A0A8-4644-9A75-16CCF3003490Q37118909-15407D9A-9961-40F9-B1ED-71022AA76CD1Q37299546-B4BF6CCC-B3FD-42E3-A6A4-3B64EAE5C732Q37519697-DBC08812-A95E-40EC-8EE2-B029E65B6E31Q37560632-A4E4A733-F0A5-484D-A181-998D56AF7CE3Q37930408-E93341F4-C50F-45A6-9E37-53B6EC56F1B1Q37987065-F27D877F-74A3-4E3F-82B0-BA5FD203937AQ38436175-3C6C646F-FDE7-423F-973E-1A9E7CCEDD67Q38620925-FEC19040-0000-4B5F-B175-9901E0277041Q39153784-A3196328-42C5-4D09-8834-490E0B86E2A8Q39169517-0D23E17F-2CCE-43AA-9515-C3A677FD5DCEQ39293213-560CFC13-6AA8-4E7A-B292-A9560F9B2890Q42841918-A81E56F5-52D1-487B-86A1-D0D86CA186CAQ44235671-583EC1B8-4D09-4902-AC33-89A2776C2D1CQ44494542-9ED8D07F-7573-4785-8967-9C1E646AD40BQ44889838-E39970FD-3C64-4C5F-8F9C-0EDB826721A6
P2860
Treatment of downbeat nystagmus with 3,4-diaminopyridine: a placebo-controlled study.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Treatment of downbeat nystagmus with 3,4-diaminopyridine: a placebo-controlled study.
@en
Treatment of downbeat nystagmus with 3,4-diaminopyridine: a placebo-controlled study.
@nl
type
label
Treatment of downbeat nystagmus with 3,4-diaminopyridine: a placebo-controlled study.
@en
Treatment of downbeat nystagmus with 3,4-diaminopyridine: a placebo-controlled study.
@nl
prefLabel
Treatment of downbeat nystagmus with 3,4-diaminopyridine: a placebo-controlled study.
@en
Treatment of downbeat nystagmus with 3,4-diaminopyridine: a placebo-controlled study.
@nl
P2093
P1433
P1476
Treatment of downbeat nystagmus with 3,4-diaminopyridine: a placebo-controlled study.
@en
P2093
Krafczyk S
Schautzer F
P304
P356
10.1212/01.WNL.0000078893.41040.56
P407
P577
2003-07-01T00:00:00Z